levofloxacin has been researched along with Communicable Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anract, P; Benaboud, S; Bouazza, N; Canouï, E; Contejean, A; Enser, M; Eyrolle, L; Gauzit, R; Hirt, D; Kerneis, S; Leclerc, P; Morand, P; Treluyer, JM; Zheng, Y | 1 |
| Cai, H; Cao, Q; Chen, Y; Deng, H; Deng, J; Hao, J; He, L; Huang, Y; Jing, C; Lin, A; Wang, C; Wu, X; Xu, H; Yang, J; Yu, H; Zhang, T | 1 |
| Baddour, LM; Kaufmann, BA; Kurz, M; Widmer, AF | 1 |
| Cristini, F; Scudeller, L; Viale, P | 1 |
| Hori, R; Kagimoto, N; Nomura, H; Okumura, K; Tanigawara, Y | 1 |
5 other study(ies) available for levofloxacin and Communicable Diseases
| Article | Year |
|---|---|
Oral levofloxacin: population pharmacokinetics model and pharmacodynamics study in bone and joint infections.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Communicable Diseases; Humans; Levofloxacin; Microbial Sensitivity Tests; Monte Carlo Method; Pseudomonas aeruginosa; Staphylococcus aureus | 2022 |
Antimicrobial resistance profile of methicillin-resistant
Topics: Abscess; Anti-Bacterial Agents; Child; Child, Preschool; Clindamycin; Communicable Diseases; Drug Resistance, Bacterial; Erythromycin; Gentamicins; Humans; Infant, Newborn; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Propionibacterium acnes prosthetic valve endocarditis with abscess formation: a case report.
Topics: Abscess; Adult; Anti-Bacterial Agents; Ceftriaxone; Communicable Diseases; Endocarditis, Bacterial; Gram-Positive Bacterial Infections; Heart Valve Prosthesis; Humans; Levofloxacin; Male; Middle Aged; Propionibacterium acnes; Prosthesis-Related Infections; Rifampin; Treatment Outcome | 2014 |
Levofloxacin: a suitable option for the infectious disease consultant.
Topics: Anti-Bacterial Agents; Communicable Diseases; Critical Illness; Cross Infection; Humans; Intensive Care Units; Levofloxacin; Ofloxacin; Referral and Consultation; Sensitivity and Specificity | 2004 |
Premarketing population pharmacokinetic study of levofloxacin in normal subjects and patients with infectious diseases.
Topics: Age Factors; Bayes Theorem; Clinical Trials as Topic; Communicable Diseases; Humans; Levofloxacin; Marketing of Health Services; Meta-Analysis as Topic; Ofloxacin | 1995 |